Abstract
The activity of antibacterial agents is difficult to assess, as in contrast with other drugs, we have to deal with three components: the patient, the pathogen, and the antibiotic. As far as antibiotics are concerned, the pharmacology is separated into two distinct components, pharmacokinetics and pharmacodynamics. Pharmacokinetics describes absorption, distribution and elimination of the drug and the pharmacodynamics describes the relationship between concentration and the antimicrobial effect. The most used pharmacodynamic parameter for antibiotics is the minimal inhibitory concentration (MIC). The relationship between inhibitory concentration and the pharmacokinetics is the basis for the calculation of the three categories of sensitivity in bacteria: sensitive, intermediate, and resistant. In addition, dosing and form of application is calculated by this pharmacodynamic and pharmacokinetic parameters: oral, parenteral, infusion, bolus injection, the amount of drug, frequency of dosing, and duration of therapy. It is questionable whether such simple calculation (MIC and concentration in the serum) can describe antimicrobial activity. The pharmacokinetic data, usually available as the total serum concentration, although only the unbound concentration is active, are used for the calculation. Futhermore, infections are usually not manifest in the serum. Nevertheless, the calculation for antibiotic therapy mainly depends on concentrations in the serum. What we really need to know is the concentration of the drug in interstitial fluid, i. e. the unbound portion. A concentration-time curve at the site of infection would be even better.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Craig WA, Ebert SC (1992) Continuous infusion of f3-lactam-antibiotics. Antimicrob Agents Chemother 36: 2577–2583
Craig WA, Suh B (1991) Protein binding and the antimicrobial effects: methods of the determination of protein binding. In: Lorian V (ed) Antibiotics in laboratory medicine, 35d edn. Williams & Wilkins, Baltimore, pp 367–401
Rustige C, Wiedemann B (1990) Antibacterial activity of lomefloxacin in an in vitro model. Antimicrob Agents Chemother 34: 1107–1111
Schentag JJ, Nix DE, Adelman MH (1991) Mathematical examination of dual individualization principles I: Relationship between AUC above MIC and AUG for cefmenoxime, ciprofloxacin and tobramycin. Ann Pharmacother 25: 1050–1057
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wiedemann, B. (1997). Pharmacodynamics of Antibiotics. In: Busse, WD., Labischinski, H., Zeiler, HJ. (eds) Antibacterial Therapy: Achievements, Problems and Future Perspectives. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60803-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-60803-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62896-5
Online ISBN: 978-3-642-60803-2
eBook Packages: Springer Book Archive